RecruitingNot Applicable

Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery

Egypt72 participantsStarted 2023-05-01

Plain-language summary

This prospective randomized controlled study will be conducted to evaluate the analgesic effect of continuous perineural infusion of methylene blue with bupivacaine on acute postoperative pain and to evaluate its preventive role against chronic phantom pain in patients undergoing lower limb amputation surgery

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of both genders, suffering from vascular insufficiency of one or both lower limbs and scheduled for above or below knee amputation under general anesthesia. Exclusion Criteria: * Patients with a history of allergy to local anesthetics. * Patients with allergy to methylene blue. * Anticoagulant use or coagulopathy.

What they're measuring

Degree of postoperative pain

Timeframe: 3 days after surgery

Trial details

NCT IDNCT05830630

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-01

Contact for this trial

Osama M Rehab, MD

00201095210806 osamarehab@med.tanta.edu.eg

View on ClinicalTrials.gov More Perineural trials